Charles River Laboratories International, Inc. (CRL) Revenue Growth
Charles River Laboratories International, Inc. (CRL) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 10.48% |
| 2018-12-31 | 21.99% |
| 2019-12-31 | 15.67% |
| 2020-12-31 | 11.55% |
| 2021-12-31 | 21.08% |
| 2022-12-31 | 12.31% |
| 2023-12-31 | 3.86% |
| 2024-12-31 | -1.92% |
| 2025-12-31 | -0.85% |
How CRL compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IART | Integra LifeSciences Holdings Corporation | 1.53% |
| BIO | Bio-Rad Laboratories Inc. Class A | 0.65% |
| BMY | Bristol-Myers Squibb Company | -0.22% |
| MYGN | Myriad Genetics Inc. | -1.56% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
These are five companies in the same sector as CRL with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Charles River Laboratories International, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CRL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CRL | $288.24 | -1.12% | 1.09M |
| 3 | ||||
| 4 | ||||
| 5 |